The great need to overcome osimertinib resistance in advanced non-small cell lung cancer: from combination strategies to fourth-generation tyrosine kinase inhibitors

Subjects

Subjects :

non-small cell lung cancer
osimertinib
resistance
tyrosine kinase inhibitor
allosteric inhibitor
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282

Details

Language :

English

ISSN :

2234943X

Volume :

13

Database :

Directory of Open Access Journals

Journal :

Frontiers in Oncology

Publication Type :

Academic Journal

Accession number :

edsdoj.2d089392ca0e43ac9eda67cf4918da8e

Document Type :

article

Full Text :

https://doi.org/10.3389/fonc.2023.1308460